Drug – bio-affecting and body treating compositions – Enzyme or coenzyme containing – Oxidoreductases
Reexamination Certificate
2006-04-18
2006-04-18
Saidha, Tekchand (Department: 1652)
Drug, bio-affecting and body treating compositions
Enzyme or coenzyme containing
Oxidoreductases
C424S094100, C435S069100, C435S189000, C536S023100, C536S023200
Reexamination Certificate
active
07029673
ABSTRACT:
The present invention relates to nucleotides encoding for the production of novel regulatory proteins for Nox enzymes involved in generation of reactive oxygen intermediates that affect cell division. The present invention also provides vectors containing these nucleotides, cells transfected with these vectors, antibodies raised against these novel proteins, kits for detection, localization and measurement of these nucleotides and proteins, and methods to determine the activity of drugs to affect the biological activity of the regulatory proteins of the present invention.
REFERENCES:
patent: 6620603 (2003-09-01), Lambeth et al.
patent: WO 00/28031 (2000-05-01), None
patent: WO01/75067 (2001-10-01), None
patent: WO 01/087957 (2001-11-01), None
patent: WO 02/081703 (2002-10-01), None
Burdon, R.H., “Superoxide and hydrogen peroxide in relation to mammalian cell proliferation,” Free Radical Biol. Med., vol. 18, No. 4, pp. 775-794 (1995).
Cheng, G., et al., Gene, 269: pp. 131-140, May 16, 2001.
Church, S.L., et al., “Increased manganese superoxide dismutase expression suppresses the malignant phenotype of human melanoma cells,” Proc. Natl. Acad. Sci. USA, vol. 90, pp. 3113-3117 (1993).
Edens, W., et al., “Tyrosine cross-linking of extracellular matrix is catalyzed by Duox, a multidomain oxidase/peroxidase with homology to the phagocyte oxidase subunit gp91phox,” J. Cell Biol., 154(4): pp. 879-891, Aug. 20, 2001.
Fernandez-Pol, J.A., et al., “Correlation between the loss of the transformed phenotype and an increase in superoxide dismutase activity in a revertant subclone of sarcoma virus-infected mammalian cells,” Can. Res., vol. 42, pp. 609-617 (1982).
Fukui, T., et al., “p22phox mRNA expression and NADPH oxidase activity are increased in aortas from hypertensive rats,” Circ. Res., vol. 80, No. 1, pp. 45-51 (1997).
Griendling, K. K., et al., “Angiotensin II stimulates NADH and NADPH oxidase activity in cultured vascular smooth muscle cells,” Circ. Res., vol. 74, No. 6, pp. 1141-1148 (1994).
Irani, K., et al., “Mitogenic signaling mediated by oxidants in ras-transformed fibroblasts,” Science, vol. 275, No. 5306, pp. 1649-1652 (1997).
Lambeth, J. D., et al., “Novel homologs of gp91phox,” Trends Biochem. Sci., (10): pp. 459-461, Oct. 25, 2000.
Li, Y., et al., “Validation of lucigenin (Bis-N-methylacridinium) as a chemilumigenic probe for detecting superoxide anion radical production by enzymatic and cellular systems,” J. Biol. Chem., vol. 273, No. 4, pp. 2015-2023 (1998).
Matsubara, T., et al., “Increased superoxide anion release from human endothelial cells in response to cytokines,” J. Immun., vol. 137, No. 10, pp. 3295-3298 (1986).
Meier, B., et al., “Human fibroblasts release reactive oxygen species in response to interleukin-1 or tumor necrosis factor-α,” Biochem. J., vol. 263, No. 2, pp. 539-545 (1989).
Pagano, P. J., et al., “Localization of a constitutively active, phagocyte-like NADPH oxidase in rabbit aortic adventitia: Enhancement by angiotensin II,” Proc. Natl. Acad. Sci. USA, vol. 94, No. 26, pp. 14483-14488 (1997).
Schmidt, K. N., et al., “The roles of hydrogen peroxide and superoxide as messengers in the activation of transcription factor NF-κB,” Chem. & Biol., vol. 2, No. 1, pp. 13-22 (1995).
Schreck, R., et al., “Reactive oxygen intermediates as apparently widely used messengers in the activation of the NF-κB transcription factor and HIV-1,” EMBO J., vol. 10, No. 8, pp. 2247-2258 (1991).
Sundaresan, M., et al., “Requirement for generation of H2O2for platelet-derived growth factor signal transduction,” Science, vol. 270, pp. 296-299 (1995).
Szatrowski, T.P., et al., “Production of large amounts of hydrogen peroxide by human tumor cells,” Canc. Res., vol. 51, No. 3, pp. 794-798 (1991).
Uhlinger, D.J., “Nucleoside triphosphate requirements for superoxide generation and phosphorylation in a cell-free system from human neutrophils,” vol. 266, No. 31, pp. 20990-20997 (1991).
Ushio-Fukai M., et al., “p22phoxis a critical component of the superoxide-generating NADH/NADPH oxidase system and regulates angiotensin II-induced hypertrophy in vascular smooth muscle cells,” J. Biol. Chem., vol. 271, No. 38, pp. 23317-23321 (1996).
Yan, T., et al., “Manganese-containing superoxide dismutase overexpression causes phenotypic reversion in SV40-transformed human lung fibroblasts,” Canc. Res., vol. 56, pp. 2864-2871 (1996).
Yu, L., et al., Biosynthesis of the phagocyte NADPH oxidase cytochrome b558, J. Biol. Chem., vol. 272, No. 43, pp. 27288-27294 (1997).
Cheng, Guangjie et al.,Journal of Biological Chemistry, vol. 279, No. 6, Feb. 6, 2004, pp. 4737-4742.
Cheng, Guangjie et al.,Journal of Biological Chemistry, vol. 279, No. 33, Aug. 13, 2004, pp. 34250-34255.
Geiszt, Miklos et al.,Journal of Biological Chemistry, vol. 278, No. 22, May 30, 2003, pp. 20006-20012.
Takeya, Ryu et al.,Journal of Biological Chemistry, vol. 278, No. 27, Jul. 4, 2003, pp. 25234-25246.
Maly et al., “Restitution of Superoxide Generation in Autosomal Cytochrome-negative Chronic Granulomatous Disease (A22° CGD)-derived B Lymphocyte Cell Lines by Transfection with p22phoxcDNA,”J. Exp. Med., vol. 178, pp. 2047-2053, 1993.
Dahan et al., Mapping of Functional Domains in the p22phoxSubunit of Flavocytochrome b559Participating in the Assembly of the NADPH Oxidase Complex by “Peptide Walking,”J. Biol. Chem., vol. 277, No. 10, pp. 8421-8432, 2002.
Sumimoto et al., “Role of Src homology 3 domains in assembly and activation of the phagocyte NADPH oxidase,”Proc. Natl, Acad. Sci. USA, vol. 91, pp. 5345-5349, 1994.
Rosei et al., “NAD(P)H oxidase: a perpetrator of cardiovascular damage,” The European Cardiologist Journal by Fax, Mar. 24, 2004.
Cheng Guangjie
Lambeth J. David
Emory University
Klarquist & Sparkman, LLP
Saidha Tekchand
LandOfFree
Regulatory protein for Nox enzymes does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Regulatory protein for Nox enzymes, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Regulatory protein for Nox enzymes will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3585433